Home > Press > Microfluidics Achieves ISO 9001:2008 Certification
Abstract:
Globally Recognized Quality Management System Assures Customers That Appropriate Systems Are In Place To Meet Specialized Needs
Microfluidics International Corporation (OTCBB:MFLU) today announced that its Quality Management System has achieved ISO 9001:2008 certification.
The certification verifies that Microfluidics has effectively applied the ISO 9001 standard to the design, manufacture and distribution of Microfluidizer® high shear fluid processors for pharmaceutical, biotechnology, chemical and allied industries. The certification was provided by United Registrar Services, LLC and authorized through TGA, The German Association for Accreditation GMBH.
"Assuring customers that we focus on understanding their requirements is the most fundamental benefit provided by ISO certification," said Michael C. Ferrara, President and Chief Executive Officer of Microfluidics. "ISO certification is ideal because it is an internationally recognized standard that spans all industries. This independent certification serves as validation that our organization is actively engaged in and committed to quality. Simply put, ISO means 'peace of mind' to customers who understand the value of utilizing a global standard as the basis for their Quality Management System."
Microfluidizer processors are engineered, constructed, customized and shipped by dedicated employees located at the company's global headquarters in Newton, MA. More than 3,000 processors - including the new LV1 Low Volume Microfluidizer processor - are installed at leading pharmaceutical, industrial and academic research institutions in more than 50 countries worldwide.
"The comprehensive approach taken to improvement activities in our Quality Management system fits very well with ISO's expectations for continuous improvement," said Bill Conroy, Senior Vice President of Operations and Engineering at Microfluidics. "Whether it is customer service, product design, production or field service, the same process standards apply for every customer around the world."
To take a virtual tour of the Microfluidics facility in Newton, MA, visit www.microfluidicscorp.com
####
About Microfluidics
Microfluidics (OTCBB: MFLU) is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative Microfluidics Technology Center, located at the company's headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.
By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results.
For more information, please click here
Contacts:
Barbara J. Rudolph
Rudolph Communications,LLC
781-229-1811
Copyright © Microfluidics
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||